Assessing the reliability to detect cerebral hypometabolism in probable Alzheimer's disease and amnestic mild cognitive impairment
Xia Wu(Beijing Institute of Technology), Eric M. Reiman(Alzheimer's Association), Gene E. Alexander(Alzheimer's Association), Norman L. Foster(University of Utah), Xiaofen Liu(Alzheimer's Association), Cole Reschke(Alzheimer's Association), Dan Bandy(Alzheimer's Association), Adam Fleisher(Banner Alzheimer’s Institute), Jessica B. Langbaum(Ludwig-Maximilians-Universität München), Robert A. Koeppe(University of Michigan), Napatkamon Ayutyanont(Alzheimer's Association), Kewei Chen(Good Samaritan Medical Center), Paul M. Thompson(University of Southern California), Li Yao(Peking University), Wendy Lee(Alzheimer's Association), Michael W. Weiner(University of California, San Francisco), William Jagust(Lawrence Berkeley National Laboratory), Danielle Harvey(UC San Diego Health System)
Cited by 16
Related Papers
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|7.1k
A probabilistic atlas and reference system for the human brain: International Consortium for Brain Mapping (ICBM)
|Philosophical Transactions of the Royal Society B Biological Sciences|2001|2.4k
Mapping cortical change across the human life span
|Nature Neuroscience|2003|2.3k